APO Research
Talk to an analyst

APO RESEARCH · REPORT

Biobanking Sample

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Biobanking Sample Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

26 December 2025194 pages

Choose your research edition.

Industry ResearchBiobanking Sample Industry Research Report 2026131 pages · $2,950 USDIndustry Growth & TrendsGlobal Biobanking Sample Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Biobanking Sample Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Biobanking Sample Market Outlook and Growth Opportunities 2026201 pages · $4,250 USDMarket Analysis & ForecastGlobal Biobanking Sample Market Analysis and Forecast 2026-2032207 pages · $4,950 USD

Market perspective

The global Biobanking Sample market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Biobanking Sample is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Biobanking Sample is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Biobanking Sample is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Biobanking Sample is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Biobanking Sample include Becton, Dickinson and Company (US), Biokryo GmbH (Germany), Brooks Automation (US), Chart Industries (US), Greiner Bio One [Greiner Holding AG, Austria)], Hamilton Company (US), LVL Technologies GmbH & Co. KG (Germany), Micronic (Netherlands) and Panasonic Healthcare Holdings Co. Ltd (Japan), among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Biobanking Sample market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Biobanking Sample and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Biobanking Sample sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Biobanking Sample market size, projected growth trends, production technologies, key applications, and end-use industries.

Biobanking Sample Segment by Company

Becton, Dickinson and Company (US)

Biokryo GmbH (Germany)

Brooks Automation (US)

Chart Industries (US)

Greiner Bio One [Greiner Holding AG, Austria)]

Hamilton Company (US)

LVL Technologies GmbH & Co. KG (Germany)

Micronic (Netherlands)

Panasonic Healthcare Holdings Co. Ltd (Japan)

Promega Corporation (US)

Qiagen N.V. (Germany)

Tecan Group Ltd. (Switzerland)

TTP Labtech Ltd (U.K.)

VWR Corporation (US)

Worthington Industries [(Taylor Wharton, US)]

Merck KGaA (Germany)

Thermo Fisher Scientific Inc(US)

Biobanking Sample Segment by Type

Nucleic Acids

Human Waste Products

Human Tissues

Biological Fluids

Cell Lines

Blood Products

Biobanking Sample Segment by Application

Clinical Research

Life Science Research

Regenerative Medicine

Biobanking Sample Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biobanking Sample market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Biobanking Sample and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biobanking Sample.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Biobanking Sample market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Biobanking Sample manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Biobanking Sample in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Biobanking Sample in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Biobanking Sample Industry Trends Table 2. Biobanking Sample Industry Drivers Table 3. Biobanking Sample Industry Opportunities and Challenges Table 4. Biobanking Sample Industry Restraints Table 5. Global Biobanking Sample Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Biobanking Sample Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Biobanking Sample Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Biobanking Sample Sales Market Share by Manufacturers Table 9. Global Biobanking Sample Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Biobanking Sample Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Biobanking Sample Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Biobanking Sample Manufacturers, Product Type & Application Table 13. Global Biobanking Sample Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Biobanking Sample by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Nucleic Acids Table 17. Major Manufacturers of Human Waste Products Table 18. Major Manufacturers of Human Tissues Table 19. Major Manufacturers of Biological Fluids Table 20. Major Manufacturers of Cell Lines Table 21. Major Manufacturers of Blood Products Table 22. Global Biobanking Sample Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 23. Global Biobanking Sample Sales by Type (2021-2026) & (K Units) Table 24. Global Biobanking Sample Sales by Type (2027-2032) & (K Units) Table 25. Global Biobanking Sample Sales Market Share by Type (2021-2026) Table 26. Global Biobanking Sample Sales Market Share by Type (2027-2032) Table 27. Global Biobanking Sample Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 28. Global Biobanking Sample Revenue by Type (2021-2026) & (K Units) Table 29. Global Biobanking Sample Revenue by Type (2027-2032) & (K Units) Table 30. Global Biobanking Sample Revenue Market Share by Type (2021-2026) Table 31. Global Biobanking Sample Revenue Market Share by Type (2027-2032) Table 32. Major Manufacturers of Clinical Research Table 33. Major Manufacturers of Life Science Research Table 34. Major Manufacturers of Regenerative Medicine Table 35. Global Biobanking Sample Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 36. Global Biobanking Sample Sales by Application (2021-2026) & (K Units) Table 37. Global Biobanking Sample Sales by Application (2027-2032) & (K Units) Table 38. Global Biobanking Sample Sales Market Share by Application (2021-2026) Table 39. Global Biobanking Sample Sales Market Share by Application (2027-2032) Table 40. Global Biobanking Sample Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 41. Global Biobanking Sample Revenue by Application (2021-2026) & (K Units) Table 42. Global Biobanking Sample Revenue by Application (2027-2032) & (K Units) Table 43. Global Biobanking Sample Revenue Market Share by Application (2021-2026) Table 44. Global Biobanking Sample Revenue Market Share by Application (2027-2032) Table 45. Global Biobanking Sample Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 46. Global Biobanking Sample Sales by Region (2021-2026) & (K Units) Table 47. Global Biobanking Sample Sales Market Share by Region (2021-2026) Table 48. Global Biobanking Sample Sales Forecasted by Region (2027-2032) & (K Units) Table 49. Global Biobanking Sample Sales Forecasted Market Share by Region (2027-2032) Table 50. North America Biobanking Sample Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 51. North America Biobanking Sample Sales by Country (2021-2026) & (K Units) Table 52. North America Biobanking Sample Sales by Country (2027-2032) & (K Units) Table 53. Europe Biobanking Sample Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. Europe Biobanking Sample Sales by Country (2021-2026) & (K Units) Table 55. Europe Biobanking Sample Sales by Country (2027-2032) & (K Units) Table 56. Asia Pacific Biobanking Sample Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. Asia Pacific Biobanking Sample Sales by Country (2021-2026) & (K Units) Table 58. Asia Pacific Biobanking Sample Sales by Country (2027-2032) & (K Units) Table 59. South America, Middle East and Africa Biobanking Sample Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 60. South America, Middle East and Africa Biobanking Sample Sales by Country (2021-2026) & (K Units) Table 61. South America, Middle East and Africa Biobanking Sample Sales by Country (2027-2032) & (K Units) Table 62. Global Biobanking Sample Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 63. Global Biobanking Sample Revenue by Region (2021-2026) & (US$ Million) Table 64. Global Biobanking Sample Revenue by Region (2027-2032) & (US$ Million) Table 65. Global Biobanking Sample Revenue Market Share by Region (2021-2026) Table 66. Global Biobanking Sample Revenue Market Share by Region (2027-2032) Table 67. Becton, Dickinson and Company (US) Company Information Table 68. Becton, Dickinson and Company (US) Business Overview Table 69. Becton, Dickinson and Company (US) Biobanking Sample Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Becton, Dickinson and Company (US) Biobanking Sample Product Portfolio Table 71. Becton, Dickinson and Company (US) Recent Development Table 72. Biokryo GmbH (Germany) Company Information Table 73. Biokryo GmbH (Germany) Business Overview Table 74. Biokryo GmbH (Germany) Biobanking Sample Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Biokryo GmbH (Germany) Biobanking Sample Product Portfolio Table 76. Biokryo GmbH (Germany) Recent Development Table 77. Brooks Automation (US) Company Information Table 78. Brooks Automation (US) Business Overview Table 79. Brooks Automation (US) Biobanking Sample Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Brooks Automation (US) Biobanking Sample Product Portfolio Table 81. Brooks Automation (US) Recent Development Table 82. Chart Industries (US) Company Information Table 83. Chart Industries (US) Business Overview Table 84. Chart Industries (US) Biobanking Sample Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Chart Industries (US) Biobanking Sample Product Portfolio Table 86. Chart Industries (US) Recent Development Table 87. Greiner Bio One [Greiner Holding AG, Austria)] Company Information Table 88. Greiner Bio One [Greiner Holding AG, Austria)] Business Overview Table 89. Greiner Bio One [Greiner Holding AG, Austria)] Biobanking Sample Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Greiner Bio One [Greiner Holding AG, Austria)] Biobanking Sample Product Portfolio Table 91. Greiner Bio One [Greiner Holding AG, Austria)] Recent Development Table 92. Hamilton Company (US) Company Information Table 93. Hamilton Company (US) Business Overview Table 94. Hamilton Company (US) Biobanking Sample Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. Hamilton Company (US) Biobanking Sample Product Portfolio Table 96. Hamilton Company (US) Recent Development Table 97. LVL Technologies GmbH & Co. KG (Germany) Company Information Table 98. LVL Technologies GmbH & Co. KG (Germany) Business Overview Table 99. LVL Technologies GmbH & Co. KG (Germany) Biobanking Sample Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. LVL Technologies GmbH & Co. KG (Germany) Biobanking Sample Product Portfolio Table 101. LVL Technologies GmbH & Co. KG (Germany) Recent Development Table 102. Micronic (Netherlands) Company Information Table 103. Micronic (Netherlands) Business Overview Table 104. Micronic (Netherlands) Biobanking Sample Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 105. Micronic (Netherlands) Biobanking Sample Product Portfolio Table 106. Micronic (Netherlands) Recent Development Table 107. Panasonic Healthcare Holdings Co. Ltd (Japan) Company Information Table 108. Panasonic Healthcare Holdings Co. Ltd (Japan) Business Overview Table 109. Panasonic Healthcare Holdings Co. Ltd (Japan) Biobanking Sample Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 110. Panasonic Healthcare Holdings Co. Ltd (Japan) Biobanking Sample Product Portfolio Table 111. Panasonic Healthcare Holdings Co. Ltd (Japan) Recent Development Table 112. Promega Corporation (US) Company Information Table 113. Promega Corporation (US) Business Overview Table 114. Promega Corporation (US) Biobanking Sample Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 115. Promega Corporation (US) Biobanking Sample Product Portfolio Table 116. Promega Corporation (US) Recent Development Table 117. Qiagen N.V. (Germany) Company Information Table 118. Qiagen N.V. (Germany) Business Overview Table 119. Qiagen N.V. (Germany) Biobanking Sample Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 120. Qiagen N.V. (Germany) Biobanking Sample Product Portfolio Table 121. Qiagen N.V. (Germany) Recent Development Table 122. Tecan Group Ltd. (Switzerland) Company Information Table 123. Tecan Group Ltd. (Switzerland) Business Overview Table 124. Tecan Group Ltd. (Switzerland) Biobanking Sample Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 125. Tecan Group Ltd. (Switzerland) Biobanking Sample Product Portfolio Table 126. Tecan Group Ltd. (Switzerland) Recent Development Table 127. TTP Labtech Ltd (U.K.) Company Information Table 128. TTP Labtech Ltd (U.K.) Business Overview Table 129. TTP Labtech Ltd (U.K.) Biobanking Sample Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 130. TTP Labtech Ltd (U.K.) Biobanking Sample Product Portfolio Table 131. TTP Labtech Ltd (U.K.) Recent Development Table 132. VWR Corporation (US) Company Information Table 133. VWR Corporation (US) Business Overview Table 134. VWR Corporation (US) Biobanking Sample Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 135. VWR Corporation (US) Biobanking Sample Product Portfolio Table 136. VWR Corporation (US) Recent Development Table 137. Worthington Industries [(Taylor Wharton, US)] Company Information Table 138. Worthington Industries [(Taylor Wharton, US)] Business Overview Table 139. Worthington Industries [(Taylor Wharton, US)] Biobanking Sample Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 140. Worthington Industries [(Taylor Wharton, US)] Biobanking Sample Product Portfolio Table 141. Worthington Industries [(Taylor Wharton, US)] Recent Development Table 142. Merck KGaA (Germany) Company Information Table 143. Merck KGaA (Germany) Business Overview Table 144. Merck KGaA (Germany) Biobanking Sample Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 145. Merck KGaA (Germany) Biobanking Sample Product Portfolio Table 146. Merck KGaA (Germany) Recent Development Table 147. Thermo Fisher Scientific Inc(US) Company Information Table 148. Thermo Fisher Scientific Inc(US) Business Overview Table 149. Thermo Fisher Scientific Inc(US) Biobanking Sample Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 150. Thermo Fisher Scientific Inc(US) Biobanking Sample Product Portfolio Table 151. Thermo Fisher Scientific Inc(US) Recent Development Table 152. Key Raw Materials Table 153. Raw Materials Key Suppliers Table 154. Biobanking Sample Distributors List Table 155. Biobanking Sample Customers List Table 156. Research Programs/Design for This Report Table 157. Authors List of This Report Table 158. Secondary Sources Table 159. Primary Sources List of Figures Figure 1. Biobanking Sample Product Image Figure 2. Global Biobanking Sample Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Biobanking Sample Market Size (2021-2032) & (US$ Million) Figure 4. Global Biobanking Sample Sales (2021-2032) & (K Units) Figure 5. Global Biobanking Sample Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Biobanking Sample Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Nucleic Acids Image Figure 9. Human Waste Products Image Figure 10. Human Tissues Image Figure 11. Biological Fluids Image Figure 12. Cell Lines Image Figure 13. Blood Products Image Figure 14. Global Biobanking Sample Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 15. Global Biobanking Sample Sales Market Share 2021 VS 2025 VS 2032 Figure 16. Global Biobanking Sample Sales Market Share by Type (2021-2032) Figure 17. Global Biobanking Sample Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 18. Global Biobanking Sample Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Biobanking Sample Revenue Market Share by Type (2021-2032) Figure 20. Clinical Research Image Figure 21. Life Science Research Image Figure 22. Regenerative Medicine Image Figure 23. Global Biobanking Sample Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 24. Global Biobanking Sample Sales Market Share 2021 VS 2025 VS 2032 Figure 25. Global Biobanking Sample Sales Market Share by Application (2021-2032) Figure 26. Global Biobanking Sample Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 27. Global Biobanking Sample Revenue Market Share 2021 VS 2025 VS 2032 Figure 28. Global Biobanking Sample Revenue Market Share by Application (2021-2032) Figure 29. North America Biobanking Sample Sales and Growth Rate (2021-2032) & (K Units) Figure 30. North America Biobanking Sample Sales Market Share by Country (2021-2032) Figure 31. U.S. Biobanking Sample Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Canada Biobanking Sample Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Mexico Biobanking Sample Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Europe Biobanking Sample Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Europe Biobanking Sample Sales Market Share by Country (2021-2032) Figure 36. Germany Biobanking Sample Sales and Growth Rate (2021-2032) & (K Units) Figure 37. France Biobanking Sample Sales and Growth Rate (2021-2032) & (K Units) Figure 38. U.K. Biobanking Sample Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Italy Biobanking Sample Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Netherlands Biobanking Sample Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Asia Pacific Biobanking Sample Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Asia Pacific Biobanking Sample Sales Market Share by Country (2021-2032) Figure 43. China Biobanking Sample Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Japan Biobanking Sample Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South Korea Biobanking Sample Sales and Growth Rate (2021-2032) & (K Units) Figure 46. Southeast Asia Biobanking Sample Sales and Growth Rate (2021-2032) & (K Units) Figure 47. India Biobanking Sample Sales and Growth Rate (2021-2032) & (K Units) Figure 48. Australia Biobanking Sample Sales and Growth Rate (2021-2032) & (K Units) Figure 49. South America, Middle East and Africa Biobanking Sample Sales and Growth Rate (2021-2032) & (K Units) Figure 50. South America, Middle East and Africa Biobanking Sample Sales Market Share by Country (2021-2032) Figure 51. Brazil Biobanking Sample Sales and Growth Rate (2021-2032) & (K Units) Figure 52. South Africa Biobanking Sample Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Saudi Arabia Biobanking Sample Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Turkey Biobanking Sample Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Argentina Biobanking Sample Sales and Growth Rate (2021-2032) & (K Units) Figure 56. UAE Biobanking Sample Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Egypt Biobanking Sample Sales and Growth Rate (2021-2032) & (K Units) Figure 58. Chile Biobanking Sample Sales and Growth Rate (2021-2032) & (K Units) Figure 59. Global Biobanking Sample Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Global Biobanking Sample Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 61. North America Biobanking Sample Revenue (2021-2032) & (US$ Million) Figure 62. North America Biobanking Sample Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Europe Biobanking Sample Revenue (2021-2032) & (US$ Million) Figure 64. Europe Biobanking Sample Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Asia-Pacific Biobanking Sample Revenue (2021-2032) & (US$ Million) Figure 66. Asia-Pacific Biobanking Sample Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. South America, Middle East and Africa Biobanking Sample Revenue (2021-2032) & (US$ Million) Figure 68. South America, Middle East and Africa Biobanking Sample Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 69. Biobanking Sample Value Chain Figure 70. Manufacturing Cost Structure Figure 71. Biobanking Sample Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • Nucleic Acids
  • Human Waste Products
  • Human Tissues
  • Biological Fluids
  • Cell Lines
  • Blood Products
Applications
  • Clinical Research
  • Life Science Research
  • Regenerative Medicine
Companies covered
  • Becton, Dickinson and Company (US)
  • Biokryo GmbH (Germany)
  • Brooks Automation (US)
  • Chart Industries (US)
  • Greiner Bio One [Greiner Holding AG, Austria)]
  • Hamilton Company (US)
  • LVL Technologies GmbH & Co. KG (Germany)
  • Micronic (Netherlands)
  • Panasonic Healthcare Holdings Co. Ltd (Japan)
  • Promega Corporation (US)
  • Qiagen N.V. (Germany)
  • Tecan Group Ltd. (Switzerland)
  • TTP Labtech Ltd (U.K.)
  • VWR Corporation (US)
  • Worthington Industries [(Taylor Wharton, US)]
  • Merck KGaA (Germany)
  • Thermo Fisher Scientific Inc(US)

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Biobanking Sample Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Biobanking Sample Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Biobanking Sample Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Biobanking Sample Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Biobanking Sample Market Dynamics
  1. 2.1 Biobanking Sample Industry Trends
  2. 2.2 Biobanking Sample Industry Drivers
  3. 2.3 Biobanking Sample Industry Opportunities and Challenges
  4. 2.4 Biobanking Sample Industry Restraints
3 Biobanking Sample Market by Manufacturers
  1. 3.1 Global Biobanking Sample Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Biobanking Sample Sales by Manufacturers (2021-2026)
  3. 3.3 Global Biobanking Sample Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Biobanking Sample Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Biobanking Sample Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Biobanking Sample Manufacturers, Product Type & Application
  7. 3.7 Global Biobanking Sample Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Biobanking Sample Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Biobanking Sample Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Biobanking Sample Tier 1, Tier 2, and Tier 3
4 Biobanking Sample Market by Type
  1. 4.1 Biobanking Sample Type Introduction
  2. 4.1.1 Nucleic Acids
  3. 4.1.2 Human Waste Products
  4. 4.1.3 Human Tissues
  5. 4.1.4 Biological Fluids
  6. 4.1.5 Cell Lines
  7. 4.1.6 Blood Products
  8. 4.2 Global Biobanking Sample Sales by Type
  9. 4.2.1 Global Biobanking Sample Sales by Type (2021 VS 2025 VS 2032)
  10. 4.2.2 Global Biobanking Sample Sales by Type (2021-2032)
  11. 4.2.3 Global Biobanking Sample Sales Market Share by Type (2021-2032)
  12. 4.3 Global Biobanking Sample Revenue by Type
  13. 4.3.1 Global Biobanking Sample Revenue by Type (2021 VS 2025 VS 2032)
  14. 4.3.2 Global Biobanking Sample Revenue by Type (2021-2032)
  15. 4.3.3 Global Biobanking Sample Revenue Market Share by Type (2021-2032)
5 Biobanking Sample Market by Application
  1. 5.1 Biobanking Sample Application Introduction
  2. 5.1.1 Clinical Research
  3. 5.1.2 Life Science Research
  4. 5.1.3 Regenerative Medicine
  5. 5.2 Global Biobanking Sample Sales by Application
  6. 5.2.1 Global Biobanking Sample Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Biobanking Sample Sales by Application (2021-2032)
  8. 5.2.3 Global Biobanking Sample Sales Market Share by Application (2021-2032)
  9. 5.3 Global Biobanking Sample Revenue by Application
  10. 5.3.1 Global Biobanking Sample Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Biobanking Sample Revenue by Application (2021-2032)
  12. 5.3.3 Global Biobanking Sample Revenue Market Share by Application (2021-2032)
6 Global Biobanking Sample Sales by Region
  1. 6.1 Global Biobanking Sample Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Biobanking Sample Sales by Region (2021-2032)
  3. 6.2.1 Global Biobanking Sample Sales by Region (2021-2026)
  4. 6.2.2 Global Biobanking Sample Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Biobanking Sample Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Biobanking Sample Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Biobanking Sample Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Biobanking Sample Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Biobanking Sample Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Biobanking Sample Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Biobanking Sample Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Biobanking Sample Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Biobanking Sample Revenue by Region
  1. 7.1 Global Biobanking Sample Revenue by Region
  2. 7.1.1 Global Biobanking Sample Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Biobanking Sample Revenue by Region (2021-2026)
  4. 7.1.3 Global Biobanking Sample Revenue by Region (2027-2032)
  5. 7.1.4 Global Biobanking Sample Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Biobanking Sample Revenue (2021-2032)
  8. 7.2.2 North America Biobanking Sample Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Biobanking Sample Revenue (2021-2032)
  11. 7.3.2 Europe Biobanking Sample Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Biobanking Sample Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Biobanking Sample Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Biobanking Sample Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Biobanking Sample Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Becton, Dickinson and Company (US)
  2. 8.1.1 Becton, Dickinson and Company (US) Company Information
  3. 8.1.2 Becton, Dickinson and Company (US) Business Overview
  4. 8.1.3 Becton, Dickinson and Company (US) Biobanking Sample Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Becton, Dickinson and Company (US) Biobanking Sample Product Portfolio
  6. 8.1.5 Becton, Dickinson and Company (US) Recent Developments
  7. 8.2 Biokryo GmbH (Germany)
  8. 8.2.1 Biokryo GmbH (Germany) Company Information
  9. 8.2.2 Biokryo GmbH (Germany) Business Overview
  10. 8.2.3 Biokryo GmbH (Germany) Biobanking Sample Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Biokryo GmbH (Germany) Biobanking Sample Product Portfolio
  12. 8.2.5 Biokryo GmbH (Germany) Recent Developments
  13. 8.3 Brooks Automation (US)
  14. 8.3.1 Brooks Automation (US) Company Information
  15. 8.3.2 Brooks Automation (US) Business Overview
  16. 8.3.3 Brooks Automation (US) Biobanking Sample Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Brooks Automation (US) Biobanking Sample Product Portfolio
  18. 8.3.5 Brooks Automation (US) Recent Developments
  19. 8.4 Chart Industries (US)
  20. 8.4.1 Chart Industries (US) Company Information
  21. 8.4.2 Chart Industries (US) Business Overview
  22. 8.4.3 Chart Industries (US) Biobanking Sample Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Chart Industries (US) Biobanking Sample Product Portfolio
  24. 8.4.5 Chart Industries (US) Recent Developments
  25. 8.5 Greiner Bio One [Greiner Holding AG, Austria)]
  26. 8.5.1 Greiner Bio One [Greiner Holding AG, Austria)] Company Information
  27. 8.5.2 Greiner Bio One [Greiner Holding AG, Austria)] Business Overview
  28. 8.5.3 Greiner Bio One [Greiner Holding AG, Austria)] Biobanking Sample Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Greiner Bio One [Greiner Holding AG, Austria)] Biobanking Sample Product Portfolio
  30. 8.5.5 Greiner Bio One [Greiner Holding AG, Austria)] Recent Developments
  31. 8.6 Hamilton Company (US)
  32. 8.6.1 Hamilton Company (US) Company Information
  33. 8.6.2 Hamilton Company (US) Business Overview
  34. 8.6.3 Hamilton Company (US) Biobanking Sample Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Hamilton Company (US) Biobanking Sample Product Portfolio
  36. 8.6.5 Hamilton Company (US) Recent Developments
  37. 8.7 LVL Technologies GmbH & Co. KG (Germany)
  38. 8.7.1 LVL Technologies GmbH & Co. KG (Germany) Company Information
  39. 8.7.2 LVL Technologies GmbH & Co. KG (Germany) Business Overview
  40. 8.7.3 LVL Technologies GmbH & Co. KG (Germany) Biobanking Sample Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 LVL Technologies GmbH & Co. KG (Germany) Biobanking Sample Product Portfolio
  42. 8.7.5 LVL Technologies GmbH & Co. KG (Germany) Recent Developments
  43. 8.8 Micronic (Netherlands)
  44. 8.8.1 Micronic (Netherlands) Company Information
  45. 8.8.2 Micronic (Netherlands) Business Overview
  46. 8.8.3 Micronic (Netherlands) Biobanking Sample Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Micronic (Netherlands) Biobanking Sample Product Portfolio
  48. 8.8.5 Micronic (Netherlands) Recent Developments
  49. 8.9 Panasonic Healthcare Holdings Co. Ltd (Japan)
  50. 8.9.1 Panasonic Healthcare Holdings Co. Ltd (Japan) Company Information
  51. 8.9.2 Panasonic Healthcare Holdings Co. Ltd (Japan) Business Overview
  52. 8.9.3 Panasonic Healthcare Holdings Co. Ltd (Japan) Biobanking Sample Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Panasonic Healthcare Holdings Co. Ltd (Japan) Biobanking Sample Product Portfolio
  54. 8.9.5 Panasonic Healthcare Holdings Co. Ltd (Japan) Recent Developments
  55. 8.10 Promega Corporation (US)
  56. 8.10.1 Promega Corporation (US) Company Information
  57. 8.10.2 Promega Corporation (US) Business Overview
  58. 8.10.3 Promega Corporation (US) Biobanking Sample Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Promega Corporation (US) Biobanking Sample Product Portfolio
  60. 8.10.5 Promega Corporation (US) Recent Developments
  61. 8.11 Qiagen N.V. (Germany)
  62. 8.11.1 Qiagen N.V. (Germany) Company Information
  63. 8.11.2 Qiagen N.V. (Germany) Business Overview
  64. 8.11.3 Qiagen N.V. (Germany) Biobanking Sample Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Qiagen N.V. (Germany) Biobanking Sample Product Portfolio
  66. 8.11.5 Qiagen N.V. (Germany) Recent Developments
  67. 8.12 Tecan Group Ltd. (Switzerland)
  68. 8.12.1 Tecan Group Ltd. (Switzerland) Company Information
  69. 8.12.2 Tecan Group Ltd. (Switzerland) Business Overview
  70. 8.12.3 Tecan Group Ltd. (Switzerland) Biobanking Sample Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Tecan Group Ltd. (Switzerland) Biobanking Sample Product Portfolio
  72. 8.12.5 Tecan Group Ltd. (Switzerland) Recent Developments
  73. 8.13 TTP Labtech Ltd (U.K.)
  74. 8.13.1 TTP Labtech Ltd (U.K.) Company Information
  75. 8.13.2 TTP Labtech Ltd (U.K.) Business Overview
  76. 8.13.3 TTP Labtech Ltd (U.K.) Biobanking Sample Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 TTP Labtech Ltd (U.K.) Biobanking Sample Product Portfolio
  78. 8.13.5 TTP Labtech Ltd (U.K.) Recent Developments
  79. 8.14 VWR Corporation (US)
  80. 8.14.1 VWR Corporation (US) Company Information
  81. 8.14.2 VWR Corporation (US) Business Overview
  82. 8.14.3 VWR Corporation (US) Biobanking Sample Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 VWR Corporation (US) Biobanking Sample Product Portfolio
  84. 8.14.5 VWR Corporation (US) Recent Developments
  85. 8.15 Worthington Industries [(Taylor Wharton, US)]
  86. 8.15.1 Worthington Industries [(Taylor Wharton, US)] Company Information
  87. 8.15.2 Worthington Industries [(Taylor Wharton, US)] Business Overview
  88. 8.15.3 Worthington Industries [(Taylor Wharton, US)] Biobanking Sample Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Worthington Industries [(Taylor Wharton, US)] Biobanking Sample Product Portfolio
  90. 8.15.5 Worthington Industries [(Taylor Wharton, US)] Recent Developments
  91. 8.16 Merck KGaA (Germany)
  92. 8.16.1 Merck KGaA (Germany) Company Information
  93. 8.16.2 Merck KGaA (Germany) Business Overview
  94. 8.16.3 Merck KGaA (Germany) Biobanking Sample Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Merck KGaA (Germany) Biobanking Sample Product Portfolio
  96. 8.16.5 Merck KGaA (Germany) Recent Developments
  97. 8.17 Thermo Fisher Scientific Inc(US)
  98. 8.17.1 Thermo Fisher Scientific Inc(US) Company Information
  99. 8.17.2 Thermo Fisher Scientific Inc(US) Business Overview
  100. 8.17.3 Thermo Fisher Scientific Inc(US) Biobanking Sample Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Thermo Fisher Scientific Inc(US) Biobanking Sample Product Portfolio
  102. 8.17.5 Thermo Fisher Scientific Inc(US) Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Biobanking Sample Value Chain Analysis
  2. 9.1.1 Biobanking Sample Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Biobanking Sample Production Mode & Process
  6. 9.2 Biobanking Sample Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Biobanking Sample Distributors
  9. 9.2.3 Biobanking Sample Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst